Katia Youssov
Inserm(FR)Université Paris-Est Créteil(FR)École Normale Supérieure - PSL(FR)Centre Hospitalier Universitaire Henri-Mondor(FR)Assistance Publique – Hôpitaux de Paris(FR)École Normale Supérieure(BI)Hôpitaux Universitaires Henri-Mondor(FR)Hôpital Albert-Chenevier(FR)Institut Mondor de Recherche Biomédicale(FR)Centre d’Investigation Clinique 1436
Publications by Year
Research Areas
Genetic Neurodegenerative Diseases, Neurological disorders and treatments, Mitochondrial Function and Pathology, Parkinson's Disease Mechanisms and Treatments, Botulinum Toxin and Related Neurological Disorders
Most-Cited Works
- → International Guidelines for the Treatment of Huntington's Disease(2019)188 cited
- → Association between caffeine intake and age at onset in Huntington's disease(2013)72 cited
- → Striatal degeneration impairs language learning: evidence from Huntington's disease(2008)67 cited
- → Expanding the Spectrum of Genes Involved in Huntington Disease Using a Combined Clinical and Genetic Approach(2016)54 cited
- → A randomized, double‐blind, placebo‐controlled trial evaluating cysteamine in Huntington's disease(2017)42 cited
- → Unified Huntington's disease rating scale for advanced patients: Validation and follow‐up study(2013)38 cited